HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.

AuthorsJ P Gockerman, M Raney, T Logan
JournalCancer treatment reports (Cancer Treat Rep) Vol. 69 Issue 9 Pg. 1029-30 (Sep 1985) ISSN: 0361-5960 [Print] United States
PMID3861247 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Antibiotics, Antineoplastic
  • Naphthacenes
  • Aclarubicin
Topics
  • Aclarubicin
  • Adenocarcinoma (drug therapy, pathology)
  • Adult
  • Aged
  • Alopecia (chemically induced)
  • Antibiotics, Antineoplastic (adverse effects, therapeutic use)
  • Breast Neoplasms (drug therapy, pathology)
  • Drug Evaluation
  • Female
  • Humans
  • Middle Aged
  • Naphthacenes (adverse effects, therapeutic use)
  • Nausea (chemically induced)
  • Neoplasm Metastasis
  • Neutropenia (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: